Eltrombopag Increases Platelet Numbers in Thrombocytopenic Patients With HCV Infection and Cirrhosis, Allowing for Effective Antiviral TherapyNezam H. Afdhal, Dickens Theodore, Mitchell L. Shiffman et al.|Gastroenterology|2013Cited by 143
Pharmacokinetics, safety and efficacy of darunavir/ritonavir in treatment-experienced children and adolescentsStéphane Blanche, Sabrina Spinosa‐Guzman, Rosa Bologna et al.|AIDS|2009Cited by 52
Long-term Follow-up of 414 HIV-Infected Romanian Children and Adolescents Receiving Lopinavir/Ritonavir-Containing Highly Active Antiretroviral TherapyMark W. Kline, Heidi Schwarzwald, Sorin Rugină et al.|PEDIATRICS|2007Cited by 31
Nine-year follow-up of HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapyRichard SB Wanless, Mark W. Kline, Sorin Rugină et al.|GERMS|2013Cited by 6
Switching from a Toxicity-Causing Antiretroviral to Enfuvirtide in Patients with HIV: The SWITCH TOX StudyAdrian Streinu‐Cercel, Matthias Stoll, Miguel Górgolas et al.|HIV Clinical Trials|2008Cited by 3